PHR (NYSE) insider sales: David Linetsky sold 13,887 shares; 107 shares vest
Rhea-AI Filing Summary
PHR Form 144 filings report proposed and recent insider sales of Common Stock. The filing lists proposed sales tied to restricted stock vesting of 40 and 67 shares with vesting dates 03/13/2026 and 03/16/2026. It also discloses prior open-market dispositions by David Linetsky totaling 13,887 shares on 01/08/2026 ($103,845.36), 01/15/2026 ($28,549.47), and 01/16/2026 ($98,762.36).
Positive
- None.
Negative
- None.
Insights
Routine Form 144 notices showing restricted‑stock vesting and recent dispositions.
The filing lists proposed sales of 40 and 67 shares tied to restricted stock vesting on 03/13/2026 and 03/16/2026. Those are small, compensation‑related issuances rather than open‑market buys.
The excerpt shows prior sales by David Linetsky totaling 13,887 shares across three dates in 01/2026 with gross proceeds shown. These past dispositions are disclosed as completed transactions; timing and amounts are explicit in the listing.
Disclosure is administrative; no new governance action or material change disclosed.
The entries identify Fidelity Brokerage Services LLC as broker and list the exchange as NYSE. The proposed sales are described as resulting from restricted stock vesting and labeled "Compensation," indicating routine compensation mechanics.
Cash‑flow treatment and any trading plan references are not included in the excerpt; subsequent filings would be needed for additional context.